Designing the next‐generation therapeutic vaccines to cure chronic hepatitis B: focus on antigen presentation, vaccine properties and effect measures

In the mid‐90s, hepatitis B virus (HBV)‐directed immune responses were for the first time investigated in detail and revealed suboptimal T‐cell responses in chronic HBV patients. Based on these studies, therapeutic vaccination exploiting the antigen presentation capacity of dendritic cells to prime...

Descripción completa

Detalles Bibliográficos
Autores principales: Jansen, Diahann TSL, Dou, Yingying, de Wilde, Janet W, Woltman, Andrea M, Buschow, Sonja I
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809700/
https://www.ncbi.nlm.nih.gov/pubmed/33489122
http://dx.doi.org/10.1002/cti2.1232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809700/
https://www.ncbi.nlm.nih.gov/pubmed/33489122
http://dx.doi.org/10.1002/cti2.1232

Ejemplares similares